Core Laboratories NV (CLB) - Net Assets
Based on the latest financial reports, Core Laboratories NV (CLB) has net assets worth $275.14 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($587.73 Million) and total liabilities ($312.58 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Explore CLB cash flow conversion to assess how effectively this company generates cash.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $275.14 Million |
| % of Total Assets | 46.81% |
| Annual Growth Rate | 6.96% |
| 5-Year Change | 73.76% |
| 10-Year Change | 80.15% |
| Growth Volatility | 56.83 |
Core Laboratories NV - Net Assets Trend (1995–2025)
This chart illustrates how Core Laboratories NV's net assets have evolved over time, based on quarterly financial data. Explore Core Laboratories NV long-term investment allocation to see how much of total assets are deployed in long-term investments.
Annual Net Assets for Core Laboratories NV (1995–2025)
The table below shows the annual net assets of Core Laboratories NV from 1995 to 2025. For live valuation and market cap data, see market value of Core Laboratories NV.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $279.76 Million | +8.55% |
| 2024-12-31 | $257.74 Million | +12.15% |
| 2023-12-31 | $229.81 Million | +21.62% |
| 2022-12-31 | $188.95 Million | +17.36% |
| 2021-12-31 | $161.00 Million | +113.04% |
| 2020-12-31 | $75.57 Million | -58.51% |
| 2019-12-31 | $182.14 Million | +13.20% |
| 2018-12-31 | $160.90 Million | +8.18% |
| 2017-12-31 | $148.73 Million | -4.23% |
| 2016-12-31 | $155.30 Million | +755.29% |
| 2015-12-31 | $-23.70 Million | -125.21% |
| 2014-12-31 | $93.99 Million | -44.51% |
| 2013-12-31 | $169.39 Million | -9.86% |
| 2012-12-31 | $187.91 Million | +3.44% |
| 2011-12-31 | $181.66 Million | -37.86% |
| 2010-12-31 | $292.34 Million | +3.76% |
| 2009-12-31 | $281.76 Million | +75.76% |
| 2008-12-31 | $160.31 Million | +151.95% |
| 2007-12-31 | $63.63 Million | -13.17% |
| 2006-12-31 | $73.28 Million | -65.97% |
| 2005-12-31 | $215.32 Million | +12.52% |
| 2004-12-31 | $191.37 Million | -13.60% |
| 2003-12-31 | $221.48 Million | -14.32% |
| 2002-12-31 | $258.49 Million | -6.49% |
| 2001-12-31 | $276.42 Million | +8.94% |
| 2000-12-31 | $253.75 Million | +20.72% |
| 1999-12-31 | $210.20 Million | +6.11% |
| 1998-12-31 | $198.10 Million | +71.81% |
| 1997-12-31 | $115.30 Million | +142.23% |
| 1996-12-31 | $47.60 Million | +27.96% |
| 1995-12-31 | $37.20 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Core Laboratories NV's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 3653.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $172.66 Million | 61.72% |
| Common Stock | $279.76 Million | 100.00% |
| Total Equity | $279.76 Million | 100.00% |
Core Laboratories NV Competitors by Market Cap
The table below lists competitors of Core Laboratories NV ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Adira Dinamika Multi Finance
JK:ADMF
|
$605.27 Million |
|
Beijing Sanlian Hope Shin-Gosen Technical Service Co Ltd
SHE:300384
|
$605.45 Million |
|
Cashway Technology Co Ltd
SHG:603106
|
$605.54 Million |
|
Sturm Ruger & Company Inc
NYSE:RGR
|
$605.75 Million |
|
China Oil HBP Science & Technology Co Ltd
SHE:002554
|
$605.01 Million |
|
Siteminder Ltd
AU:SDR
|
$604.91 Million |
|
Xiamen Hexing Packaging Printing Co Ltd
SHE:002228
|
$603.69 Million |
|
Alltek Technology Corp
TW:3209
|
$603.67 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Core Laboratories NV's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 251,991,000 to 279,760,000, a change of 27,769,000 (11.0%).
- Net income of 29,669,000 contributed positively to equity growth.
- Dividend payments of 1,869,000 reduced retained earnings.
- Share repurchases of 12,426,000 reduced equity.
- Other comprehensive income increased equity by 5,769,000.
- Other factors increased equity by 6,626,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $29.67 Million | +10.61% |
| Dividends Paid | $1.87 Million | -0.67% |
| Share Repurchases | $12.43 Million | -4.44% |
| Other Comprehensive Income | $5.77 Million | +2.06% |
| Other Changes | $6.63 Million | +2.37% |
| Total Change | $- | 11.02% |
Book Value vs Market Value Analysis
This analysis compares Core Laboratories NV's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.33x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 15.12x to 2.33x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1995-12-31 | $0.93 | $14.02 | x |
| 1996-12-31 | $1.06 | $14.02 | x |
| 1997-12-31 | $2.19 | $14.02 | x |
| 1998-12-31 | $3.26 | $14.02 | x |
| 1999-12-31 | $3.22 | $14.02 | x |
| 2000-12-31 | $3.75 | $14.02 | x |
| 2001-12-31 | $4.02 | $14.02 | x |
| 2002-12-31 | $3.89 | $14.02 | x |
| 2003-12-31 | $3.53 | $14.02 | x |
| 2004-12-31 | $3.31 | $14.02 | x |
| 2005-12-31 | $3.82 | $14.02 | x |
| 2006-12-31 | $1.34 | $14.02 | x |
| 2007-12-31 | $1.27 | $14.02 | x |
| 2008-12-31 | $3.30 | $14.02 | x |
| 2009-12-31 | $5.99 | $14.02 | x |
| 2010-12-31 | $6.00 | $14.02 | x |
| 2011-12-31 | $3.68 | $14.02 | x |
| 2012-12-31 | $3.95 | $14.02 | x |
| 2013-12-31 | $3.68 | $14.02 | x |
| 2014-12-31 | $2.11 | $14.02 | x |
| 2015-12-31 | $-0.55 | $14.02 | x |
| 2016-12-31 | $3.52 | $14.02 | x |
| 2017-12-31 | $3.36 | $14.02 | x |
| 2018-12-31 | $3.62 | $14.02 | x |
| 2019-12-31 | $3.98 | $14.02 | x |
| 2020-12-31 | $1.59 | $14.02 | x |
| 2021-12-31 | $3.35 | $14.02 | x |
| 2022-12-31 | $3.94 | $14.02 | x |
| 2023-12-31 | $4.73 | $14.02 | x |
| 2024-12-31 | $5.28 | $14.02 | x |
| 2025-12-31 | $6.02 | $14.02 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Core Laboratories NV utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 10.61%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.63%
- • Asset Turnover: 0.88x
- • Equity Multiplier: 2.13x
- Recent ROE (10.61%) is below the historical average (43.59%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1995 | 11.32% | 5.24% | 1.23x | 1.76x | $490.00K |
| 1996 | 16.24% | 7.31% | 1.32x | 1.68x | $2.96 Million |
| 1997 | 13.50% | 7.17% | 0.90x | 2.09x | $3.99 Million |
| 1998 | 10.15% | 6.99% | 0.82x | 1.77x | $300.00K |
| 1999 | 1.63% | 1.12% | 0.84x | 1.73x | $-17.49 Million |
| 2000 | 7.60% | 5.70% | 0.82x | 1.63x | $-6.03 Million |
| 2001 | 7.49% | 5.48% | 0.86x | 1.59x | $-6.93 Million |
| 2002 | -3.51% | -2.48% | 0.87x | 1.63x | $-34.88 Million |
| 2003 | 8.48% | 4.61% | 0.96x | 1.91x | $-3.34 Million |
| 2004 | 6.46% | 2.88% | 1.10x | 2.04x | $-6.74 Million |
| 2005 | 14.57% | 6.46% | 1.23x | 1.84x | $9.79 Million |
| 2006 | 115.07% | 14.36% | 1.15x | 6.98x | $75.48 Million |
| 2007 | 194.88% | 18.06% | 1.33x | 8.12x | $114.89 Million |
| 2008 | 90.80% | 18.39% | 1.45x | 3.40x | $127.79 Million |
| 2009 | 40.66% | 16.33% | 1.06x | 2.36x | $85.67 Million |
| 2010 | 50.06% | 18.24% | 1.25x | 2.20x | $115.97 Million |
| 2011 | 103.81% | 20.35% | 1.50x | 3.40x | $166.89 Million |
| 2012 | 114.98% | 22.02% | 1.54x | 3.39x | $197.28 Million |
| 2013 | 143.35% | 22.62% | 1.62x | 3.90x | $225.87 Million |
| 2014 | 273.94% | 23.73% | 1.61x | 7.19x | $248.09 Million |
| 2015 | 0.00% | 14.40% | 1.28x | 0.00x | $117.22 Million |
| 2016 | 41.14% | 10.74% | 1.04x | 3.69x | $48.37 Million |
| 2017 | 55.89% | 12.60% | 1.13x | 3.93x | $68.25 Million |
| 2018 | 49.43% | 11.35% | 1.08x | 4.03x | $63.44 Million |
| 2019 | 57.34% | 15.26% | 0.86x | 4.36x | $84.20 Million |
| 2020 | -136.53% | -20.04% | 0.86x | 7.95x | $-104.79 Million |
| 2021 | 12.61% | 4.19% | 0.81x | 3.71x | $4.08 Million |
| 2022 | 10.56% | 3.97% | 0.85x | 3.14x | $1.03 Million |
| 2023 | 16.31% | 7.19% | 0.87x | 2.61x | $14.19 Million |
| 2024 | 12.46% | 5.99% | 0.89x | 2.34x | $6.20 Million |
| 2025 | 10.61% | 5.63% | 0.88x | 2.13x | $1.69 Million |
Industry Comparison
This section compares Core Laboratories NV's net assets metrics with peer companies in the Oil & Gas Equipment & Services industry.
Industry Context
- Industry: Oil & Gas Equipment & Services
- Average net assets among peers: $2,759,980,520
- Average return on equity (ROE) among peers: 7.08%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Core Laboratories NV (CLB) | $275.14 Million | 11.32% | 1.14x | $605.25 Million |
| ProFrac Holding Corp. (ACDC) | $1.33 Billion | -7.35% | 1.31x | $980.32 Million |
| Atlas Energy Solutions Inc. (AESI) | $1.21 Billion | -4.16% | 0.84x | $2.27 Billion |
| Archrock Inc (AROC) | $860.69 Million | 5.15% | 2.02x | $6.37 Billion |
| Baker Hughes Co (BKR) | $17.05 Billion | 17.47% | 1.25x | $62.70 Billion |
| ChampionX Corporation (CHX) | $1.83 Billion | 17.49% | 0.90x | $4.94 Billion |
| Drilling Tools International Corp. (DTI) | $122.87 Million | -3.06% | 0.81x | $100.11 Million |
| Dawson Geophysical Company (DWSN) | $63.72 Million | 17.00% | 0.57x | $97.51 Million |
| Enerflex Ltd. (EFXT) | $1.21 Billion | 8.14% | 0.88x | $3.09 Billion |
| Forum Energy Technologies Inc (FET) | $1.16 Billion | 13.03% | 0.63x | $606.36 Million |
About Core Laboratories NV
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and … Read more